The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ji, Yuan
One or more keywords matched the following items that are connected to Ji, Yuan
Item TypeName
Concept Dose-Response Relationship, Immunologic
Concept Immunosuppressive Agents
Concept Dose-Response Relationship, Drug
Concept Immunohistochemistry
Concept Immunotherapy, Adoptive
Concept Topoisomerase I Inhibitors
Concept Cyclin-Dependent Kinase Inhibitor p21
Concept Immunoprecipitation
Concept Immunomodulation
Concept Histone Deacetylase Inhibitors
Concept Inhibitory Concentration 50
Concept X-Linked Inhibitor of Apoptosis Protein
Concept Cell Cycle Checkpoints
Concept S Phase Cell Cycle Checkpoints
Concept Immunity
Academic Article Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Academic Article Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.
Academic Article Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.
Academic Article Dose-finding in phase I clinical trials based on toxicity probability intervals.
Academic Article Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Academic Article The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma.
Academic Article A modified toxicity probability interval method for dose-finding trials.
Academic Article Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials.
Academic Article Risk-group-specific dose finding based on an average toxicity score.
Academic Article Incidence and risk factors of venous thromboembolic events in lymphoma.
Academic Article An integrated dose-finding tool for phase I trials in oncology.
Academic Article Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials.
Academic Article A Bayesian hierarchical model for inference across related reverse phase protein arrays experiments.
Academic Article A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2.
Academic Article The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.
Academic Article R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trials.
Academic Article An Oncolytic Adenovirus Targeting Transforming Growth Factor ß Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
Academic Article The i3+3 design for phase I clinical trials.
Academic Article Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size.
Academic Article The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines.
Academic Article Monitoring late-onset toxicities in phase I trials using predicted risks.
Academic Article [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Academic Article [Effect of Sudan I, III and IV on proliferation of HepG-2 and SGC-7901].
Academic Article Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
Academic Article Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.
Academic Article [Studies of betuionic acid on cell cycle and related protein expressions on mice of bearing H22 tumor cells].
Academic Article Downregulation of Cdk1 and cyclinB1 expression contributes to oridonin-induced cell cycle arrest at G2/M phase and growth inhibition in SGC-7901 gastric cancer cells.
Academic Article Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease.
Concept Antineoplastic Agents, Immunological
Concept Drug-Related Side Effects and Adverse Reactions
Academic Article A Multi-Arm Two-Stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials.
Search Criteria
  • immune
  • related
  • Adverse
  • Events
  • checkpoint
  • inhibitor
  • immunotherapy